Clinical Trial Update: Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating systemic ketamine for improving post-operative analgesia in alcohol-dependent patients has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Head and Neck Cancer

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Alcoholic Patient, Carcinological Surgery ORL | Phase 3 | Status: SUSPENDED